Long-Term Liabilities: The sum of all non-current liabilities.
Virax Biolabs Group Limited (VRAX) had Long-Term Liabilities of $0.28M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.15M |
|
$1.28M |
|
$1.57M |
|
$5.71M |
|
$0.37M |
|
-- |
|
|
Long-Term Liabilities |
$0.28M |
$0.64M |
|
$5.07M |
|
$5.07M |
|
$5.07M |
|
6.54M |
|
| Cash Flow Statement Financials | |
$-2.76M |
|
$-0.14M |
|
$2.02M |
|
$4.23M |
|
$3.35M |
|
$-0.88M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|